OncoHealth Corp.

OncoHealth Corp. is dedicated to providing innovative healthcare solutions centered on oncology. The company specializes in diagnostics and therapeutic services to improve patient outcomes in cancer treatment. Founded in 2009 in San Jose, US, OncoHealth Corp.

focuses on oncology healthcare solutions. In May 2022, Arsenal Capital Partners and McKesson Corporation acquired OncoHealth Corp. for undisclosed financial terms. The company has completed five deals overall, with its latest funding round being a Seed round that raised USD 0.

60 mn from investors including Band of Angels, InnoSpring, and TSVC. OncoHealth Corp. specializes in providing healthcare solutions focused on oncology and related fields. Their offerings include diagnostic and therapeutic services aimed at enhancing cancer treatment outcomes.

These products address critical needs such as early detection, effective treatment protocols, and comprehensive patient management. Healthcare providers, hospitals, and oncology specialists are the primary users of these services, which are available across North America, Europe, and parts of Asia. OncoHealth Corp. generates revenue through service contracts and partnerships with healthcare institutions, primarily through B2B transactions.

Clients subscribe to their oncology solutions, with contracts offering access to proprietary diagnostic tools and ongoing support for treatment protocols. Pricing plans are structured to accommodate the scale and complexity of services provided, making their flagship offerings integral to the revenue stream. Following the acquisition in May 2022, OncoHealth Corp. plans to innovate and enhance its oncology-specific digital health solutions for cancer patients.

The company is targeting the development of new products and intends to expand its market reach into additional regions by leveraging the recent funding of USD 0. 60 mn. This investment will support their initiatives in providing advanced healthcare solutions to improve patient care.